Milk Thistle

Silybum marianum

Family: Asteraceae Part used: Seeds

Key Compounds

• Silybin A
• Silybin B
• Isosilybin A
• Isosilybin B
• Silychristin
• Silydianin
• Silymarin (complex)
• Taxifolin
• Silibinin
• 2,3-Dehydrosilybin

Traditional Use

• Amanita phalloides (death cap) poisoning antidote — intravenous silybin (Legalon SIL) is used in European hospitals as emergency treatment for death cap mushroom poisoning; silybin blocks the OATP1B3 hepatic uptake transporter that death cap toxins use to enter liver cells; approved for this use in multiple European countries
• Chronic liver disease — WHO monograph supports use for toxic liver damage, chronic inflammatory liver conditions, and hepatic cirrhosis as supportive treatment; the most studied hepatoprotective herb with the most clinical evidence
• Hepatitis B and C — multiple trials showing modest reduction in serum transaminase levels (ALT, AST) indicating reduced liver inflammation; not curative but supportive alongside antiviral treatment
• Non-alcoholic fatty liver disease (NAFLD) — silymarin shown in several RCTs to reduce liver inflammation and improve histological markers in NAFLD; mechanism involves antioxidant protection and anti-inflammatory activity
• Alcoholic liver disease — traditional and modern use for hepatoprotection in alcohol-related liver damage; supported by laboratory evidence and some clinical trials
• Traditional European medicine — the white-veined leaves identified with Virgin Mary's milk in medieval European legend; used in German, Italian, and broader European herbal medicine since the 16th century for liver and gallbladder conditions

European hospitals keep an intravenous preparation of milk thistle compound for emergencies.

Specifically: for Amanita phalloides poisoning — the death cap mushroom. When someone eats a death cap and gets to hospital in time, one treatment they may receive is intravenous silibinin (trade name Legalon SIL), derived from milk thistle seeds. It blocks the transport protein that death cap toxins use to enter liver cells. It limits how much of the toxin gets in. It does not reverse damage already done. Arriving early matters.

This is a specific, mechanistic, emergency-medicine application of a herbal compound. It is approved and used in European countries. It is not a wellness supplement story.

The same plant has white-veined leaves that legend says are marked by the Virgin Mary’s milk, grows as a beautiful purple-flowered thistle across the Mediterranean and European countryside, and has the best-evidenced general liver-protective profile of any herb in clinical medicine.

Meet the plant

A biennial thistle, 60–150 cm, with deeply lobed, spiny-margined leaves that are dark glossy green with white marbling along the veins. The flower heads are purple, surrounded by sharp-spined bracts. The white vein markings are the immediate identification feature — no other common thistle has this.

The plant is native to the Mediterranean and southern Europe, naturalised across North America, Australia, and temperate Asia. It grows on disturbed ground: roadsides, overgrazed pasture, waste ground.

The seeds — technically achenes — are the medicinal part. Dark, glossy, slightly flattened, contained in the white silky pappus that carries them on the wind. They look like small sunflower seeds. The silymarin complex concentrates in the seed.

The Virgin Mary’s milk

The white markings on milk thistle leaves have a legend: drops of the Virgin Mary’s milk, fallen onto the leaves, created the patterns that have been there ever since.

This is why the plant is marianum — named after Mary. And why it appears in medieval European monastery gardens, cultivated by monks who accepted the association. The connection to Mary — a protective, healing figure in medieval European Christian culture — contributed to the herb’s medical status. Monks who cultivated medicinal gardens grew it. Physicians who respected the monastic tradition used it.

The underlying biology of the white markings is mundane: they are caused by reduced chlorophyll in the cells bordering the veins. The cultural history built on top of this mundane biology is not.

The death cap story

Amanita phalloides is responsible for the majority of fatal mushroom poisonings globally. The death cap is widespread in Europe and has established populations in North America, Australia, and parts of Asia. It looks similar to several edible species. Inexperienced foragers mistake it. The toxins — primarily alpha-amanitin — work by blocking RNA polymerase II inside hepatocytes, preventing protein synthesis. The cells die. The liver fails. Without treatment, the outcome is often fatal.

The toxins enter hepatocytes via OATP1B3 — an organic anion transporting polypeptide, a protein on hepatocyte cell surfaces that normally transports bile acids and other organic molecules. Silybin, the primary component of silymarin, inhibits OATP1B3 competitively. With the transporter occupied by silybin, less toxin gets in.

Intravenous silibinin (Legalon SIL) is approved for this use in Germany and other European countries. The treatment window matters — most effective within 24–48 hours, before the toxin load already absorbed has done its damage. European poison control protocols include it.

This is a mechanistically clean story: identified target, identified inhibitor, approved use. The herb that monks grew because of a milk legend provides the emergency medicine compound that blocks a poison entry mechanism identified in 20th-century pharmacology.

The chemistry

Silymarin is not a single compound. It is a mixture of isomers — flavonolignans — extracted from the seeds:

Silybin A and Silybin B are the primary components and the most pharmacologically active. Together they make up about 50–70% of silymarin. Silybin B is more active than silybin A for most applications.

Isosilybin A and Isosilybin B are diastereomers of silybin. Present in smaller amounts; contribute to the overall activity.

Silychristin and silydianin are the remaining major flavonolignans.

Taxifolin is a flavonoid (not a flavonolignan) also present in silymarin extracts.

The silymarin concentration in commercial preparations is 70–80%. Absorption from oral preparations is limited (23–47%) because silymarin is poorly water-soluble. Phospholipid complexes (phytosomes) and micronised preparations improve bioavailability.

What people actually do with it

Standardised extract (hepatoprotective use): 140–200 mg silymarin (70–80% standardised), 1–3 times daily. Take with food to enhance absorption of the fat-soluble compounds. Consistent use over several weeks to months for chronic liver support.

Silymarin phytosome: Phospholipid-complexed silybin has approximately 4–7× better bioavailability than standard silymarin extract. Available under the brand name Silybin-Phytosome (Thisilyn Advance) and generic equivalents. Lower dose required; more expensive.

Ground seeds: 1–2 teaspoons of freshly ground milk thistle seeds added to smoothies, yoghurt, or cereal. The seed contains the silymarin complex; grinding exposes it but does not standardise it. Lower and variable dose compared to extract. Nutritious — the seeds also contain protein, fat, and vitamin E.

Traditional decoction: Crushed seeds simmered in water. Less efficient than standardised extraction but traditional form.

Could you grow this yourself?

Yes. Milk thistle is straightforward to grow and naturalises easily.

The plant is biennial: it germinates and grows as a rosette in year one, then flowers and seeds in year two. Direct sow in spring or autumn in well-drained soil with full sun. It tolerates poor soil and is drought-tolerant once established. The seeds germinate readily.

Harvest: in the second year, when the flower heads begin to turn brown and the seeds ripen, cut the heads, dry, and thresh to release the seeds. Mill or grind for use. Store in an airtight container.

Caution: it self-seeds aggressively. In a garden setting, remove spent heads before they fully ripen or it will spread significantly. In suitable conditions it will return year after year. In Japan it grows in disturbed ground in warmer regions.

Milk thistle (マリアアザミ) in Japan

Milk thistle does not have a traditional role in Japanese herbal medicine. It is not a kampo ingredient and does not appear in the Japanese Pharmacopoeia as a traditional crude drug.

Japanese awareness of milk thistle — マリアアザミ (Maria azami, Mary’s thistle) or シリマリン (silymarin) — is primarily through the global Western herbal supplement market. Standardised silymarin extract capsules are available at supplement retailers and natural food stores. The positioning in Japan emphasises liver protection, which connects to Japanese health culture concerns about alcohol-related liver health and hepatitis B/C rates historically higher in Japan than in some Western countries.

The death cap poisoning application is medically relevant in Japan, where Amanita species grow in forests and mushroom poisoning occurs. However, the IV silibinin treatment protocol is more established in European clinical practice; Japanese hospital emergency management of mushroom poisoning primarily uses supportive care, liver transplant referral, and other interventions.

Wild milk thistle has naturalised in parts of Japan as an introduced species from Europe and appears in disturbed ground and roadsides, particularly in Hokkaido and warmer regions.

Things you’re probably wondering

How does it treat death cap poisoning? Silybin blocks OATP1B3, the transport protein that death cap toxins use to enter liver cells. Given intravenously (Legalon SIL) within 24–48 hours of ingestion, it limits further toxin uptake. Standard emergency protocol in European hospitals.

What is silymarin? A mixture of flavonolignan isomers extracted from milk thistle seeds: silybin A and B, isosilybin A and B, silychristin, silydianin, and taxifolin. The standardised extract contains 70–80% silymarin. Silybin is the most active component.

What does the research show? Strongest evidence: hepatoprotection from toxic damage (mechanistically established, approved pharmaceutical in Germany). Moderate evidence: reduced liver enzyme levels (ALT/AST) in hepatitis B/C and NAFLD. The WHO monograph supports use for toxic liver damage and chronic inflammatory liver conditions.

What is the legend of the white markings? The markings are said to be the Virgin Mary’s milk — drops that fell on the leaves. This is the origin of the name marianum. The legend contributed to the herb’s status in medieval European monastery gardens.

Botanical details

The full compound list

See Also

• Turmeric — overlapping hepatoprotective and anti-inflammatory applications; often combined with silymarin in liver support formulas
• Dandelion — traditional liver and digestive herb; complementary to milk thistle in European herbal hepatoprotection
• Andrographis — NF-κB inhibitor with hepatoprotective and anti-inflammatory activity

References

• Saller, R. et al. (2001). An updated systematic review with meta-analysis of clinical evidence on silymarin and liver disease. Forschende Komplementärmedizin, 8(1), 7–28.
• Abenavoli, L. et al. (2010). Milk thistle in liver diseases: past, present, future. Phytotherapy Research, 24(10), 1423–1432.
• Flaig, T.W. et al. (2010). Intravenous silymarin for treating hepatotoxic mushroom poisoning. Gastroenterology, 139(2), 386–389.
• Federico, A. et al. (2017). Silymarin/silybin and chronic liver disease. Antioxidants (Basel), 6(4), 100.